Pod pogojem, da ni razlogov za predvidevanje, da ostanki zadevnih snovi pri predlagani mejni vrednosti predstavljajo tveganje za zdravje potrošnika, se lahko določijo najvišje dovoljene količine zaostankov v Prilogi I k Uredbi (EGS) št. 2377/90. Vendar glede na celovito evalvacijo ocene tveganja glede hormonov progestagena, kar se tiče morebitnih preseženih vnosov zaostankov hormonov in njihovih metabolitov, je treba redno proučevati možna tveganja za potrošnika na osnovi novih znanstvenih dokazov.
Provided that there are no grounds for supposing that residues of the substance concerned at the level proposed present a hazard for the health of the consumer, maximum residue limits may be established in Annex I of Regulation (EEC) No 2377/90. However, given the overall evaluation on the risk assessments of progestagen hormones, as concerns possible excess intake of hormone residues and their metabolites, a possible risk to the consumer needs to be regularly reviewed on the basis of any new scientific evidence.